Venus Medtech (Hangzhou) Inc.

📍 Hangzhou, China🗓 Founded 2009👥 54 employees💰 Last funded 2013
Medical Equipment Manufacturing🌐 venusmedtech.com
Website LinkedIn
Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018. The Company’s self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in Venus Medtech (Hangzhou) Inc.?
Venus Medtech (Hangzhou) Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did Venus Medtech (Hangzhou) Inc. last raise funding?
The most recent investment in Venus Medtech (Hangzhou) Inc. recorded on gritt.io was in 2013.
When was Venus Medtech (Hangzhou) Inc. founded?
Venus Medtech (Hangzhou) Inc. was founded in 2009.
What industry is Venus Medtech (Hangzhou) Inc. in?
Venus Medtech (Hangzhou) Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Venus Medtech (Hangzhou) Inc. based?
Venus Medtech (Hangzhou) Inc. is headquartered in Hangzhou, China.